symbol,synonyms,gene_locus,gene_id,transcript_id,conservation,conservation_ortholog,conservation_species,biological_context,context_detail,tissue/cell line,genome_variation,variation_detail,epigenetic_modification,modification_detail,expression,expression_detail,regulator_type,regulator,regulator_interaction,regulator_effect,target_type,target,target_interaction,target_effect,experimental_method,molecular_function,biological_process,pathway,functional_mechanism,clinical_detail,drug,description,pmid
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Array,NA,NA,NA,NA,NA,NA,"Association identified by gwas (rs10757274,a>g,rs2383206,a>g).",17478681
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Array,NA,NA,NA,NA,NA,NA,"Sequence polymorphisms in a 58-kilobase (kb) interval on chromosome 9p21 confer a markedly increased risk (rs3217992,a>g,rs1063192,c>t) of coronary artery disease (cad),the leading cause of death worldwide.",17554300
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,NA,SNP,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Array,NA,NA,NA,NA,NA,NA,"Susceptibility to coronary artery disease and diabetes is encoded by distinct,tightly linked snps (rs2891168,a>g) in the anril locus on chromosome 9p.",18048406
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Array,NA,NA,NA,NA,NA,NA,"Chd and periodontitis are genetically related by at least one susceptibility locus,which is possibly involved in anril activity and independent of diabetes associated risk variants within this region.Elucidation of the interplay of anril transcript variants and their involvement in increased susceptibility to the interactive diseases chd and periodontitis promises new insight into the underlying shared pathogenic mechanisms of these complex common diseases.Association of a genetic susceptibility locus (rs2891168,a>g,rs1333042,a>g,rs1333048,a>c).",19214202
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,NA,NA,NA,NA,NA,RNA,Differentially expressed,NA,NA,NA,NA,NA,NA,NA,NA,Array,NA,NA,NA,NA,NA,NA,"Significantly reduced expression of all ink4/arf transcripts (p15(ink4b),p16(ink4a),arf and anril) was found in pbtl of individuals harboring a common snp (rs10757278) associated with increased risk of coronary artery disease,stroke and aortic aneurysm.",19343170
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,NA,NA,NA,NA,NA,RNA,Differentially expressed,NA,NA,NA,NA,NA,NA,NA,NA,Array,NA,Cancer proliferation,NA,NA,NA,NA,"Whole blood rna expression of the short variants of anril was increased by 2.2-fold whereas expression of the long anril variant was decreased by 1.2-fold in healthy subjects homozygous for the risk allele.Expression levels of the long and short anril variants were positively correlated with that of the cyclin-dependent kinase inhibitor,cdkn2b (p15) and tdgf1 (cripto),respectively.Whole blood rna expression of the short variants of anril was increased by 2.2-fold whereas expression of the long anril variant was decreased by 1.2-fold in healthy subjects homozygous for the risk allele.",19592466
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,NA,NA,NA,NA,NA,RNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Meta-analysis,NA,NA,NA,NA,NA,NA,"Risk snps for coronary disease,stroke,diabetes,melanoma,and glioma were all associated with allelic expression of anril (all p<0.05 after correction for multiple testing),while association with the other two genes was only detectable for some risk snps.Snps had an inverse effect on anril and cdkn2b expression,supporting a role of antisense transcription in cdkn2b regulation.Our study suggests that modulation of anril expression mediates susceptibility to several important human diseases.",20386740
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,Blood;Primary aortic sooth muscle cell,NA,NA,NA,NA,RNA,Down-regulated,NA,NA,NA,NA,NA,NA,NA,NA,Array,NA,NA,NA,NA,NA,NA,"While the exact role of anril awaited further elucidation,common disease genomewide association studies (gwas) have surprisingly identified the anril gene as a genetic susceptibility locus shared associated by coronary disease,intracranial aneurysm and also type 2 diabetes.",20956613
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,Wi38,NA,NA,NA,NA,RNA,Down-regulated,NA,NA,NA,NA,NA,NA,NA,NA,Array,NA,NA,NA,Transcriptional regulation,NA,NA,"Therefore,it is possible that the deregulation of anril by such risk-associated single-nucleotide polymorphisms changes the expression level of p15ink4b and/or other target genes,leading to the development of type 2 diabetes or coronary heart disease in humans.Quantitative reverse transcriptase pcr analysis showed that silencing anril resulted in an increase of p15ink4b expression by nearly 8-fold,but had minimal effect on the expression of p16ink4a (increased by 1.8-fold) or p14arf.",21151178
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,NA,NA,NA,NA,NA,RNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Meta-analysis,NA,NA,NA,NA,NA,NA,Anril expression may involve in the mechanisms of chromosome 9p21 on cad development.,23091611
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,NA,NA,NA,NA,NA,RNA,Differentially expressed,NA,NA,NA,NA,NA,NA,NA,NA,Array,NA,NA,NA,NA,NA,NA,"However,overexpression of 1 anril variant altered the expression of many genes involved in nuclear regulation and chromatin architecture,indicating diverse trans-regulatory effects that go beyond the cis-effects seen at 9p21.",23104877
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,NA,NA,NA,NA,NA,RNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Meta-analysis,NA,NA,NA,NA,NA,NA,Complex regulatory variation affecting anril and  cdkn2b gene expression may contribute to increased risk for clinically apparent and subclinical coronary artery disease and aortic disease.,23315372
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Meta-analysis,NA,NA,NA,NA,NA,NA,"Furthermore,genome wide association studies have identified the anril gene as a risk locus for coronary disease,intracranial aneurism,type 2 diabetes and several cancers including glioma.",24624135
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,Blood,NA,NA,NA,NA,RNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Array,NA,NA,NA,NA,NA,NA,A significant association of cdkn2bas polymorphism rs4977574 with the risk of chd under a recessive inheritance model in females.,25268619
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,NA,NA,NA,NA,NA,RNA,Up-regulated,NA,NA,NA,NA,TF,YY1,RNA-RNA,NA,Rip;Q-RCR;Meta-analysis,NA,Inflammatory response,NA,NA,NA,NA,"The newly identified tnf-nf-κb-anril/yy1-il6/8 pathway enhances understanding of the etiology of cad and provides potential therapeutic target for treatment of cad.Long non-coding rna anril regulates inflammatory responses as a novel component of nf-kb pathway.For the first time,weestablish the connection between anril and nf-kb pathway and show that anril regulates inflammatory responses through binding with yy1.The newly identified tnf-alpha-nf-kb-anril/yy1-il6/8 pathway enhances understanding of the etiology of cad and provides potential therapeutic target for treatment of cad.",26618242
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,Coronary heart disease tissue,NA,NA,DNA methylation,promoter methylation,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pyrosequencing;Q-RCR,NA,NA,NA,NA,NA,NA,Our findings suggest developmental epigenetic regulation of ANRIL promoter methylation as a factor in later CHD risk in children.,27594927
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,Coronary artery disease tissue,NA,NA,NA,NA,RNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Q-RCR;Meta-analysis,NA,NA,NA,NA,NA,NA,"Anril rs2383207polymorphism was associated with a significantly an increased risk of cad (or=1.47/ 95%ci,1.33-1.62).",27894414
CDKN2B-AS1,ANRIL;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12;CDKN2BAS,9p21.3,,,,NA,,Disease,coronary artery disease,Gse20680;Gse20681,NA,NA,NA,NA,RNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Q-RCR,NA,NA,NA,NA,NA,NA,"Only one lncRNA cdkn2b-as targeting mir-92a was obtained.Finally,gata2,map1b and arg1 were involved in the cdkn2b-as-mir-92a-feature gene regulatory network.",28760552
DBH-AS1,BPR;NCRNA00118,9q34.2,HSALNG0141604,"HSALNT0289493,HSALNT0355282,HSALNT0355283,HSALNT0355284",,NA,,Disease,coronary artery disease,NA,NA,NA,DNA methylation,cg14007688,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,30470965
GAS5,SNHG2;NCRNA00030,1q25.1,HSALNG0008545,"HSALNT0017659,HSALNT0017660,HSALNT0017661,HSALNT0017663,HSALNT0017666,HSALNT0017667,HSALNT0017670,HSALNT0017671,HSALNT0017679,HSALNT0017696,HSALNT0017697,HSALNT0017700,HSALNT0017701,HSALNT0017702,HSALNT0017703,HSALNT0017704,HSALNT0017705,HSALNT0017706,HSALNT0017716,HSALNT0017717,HSALNT0017719,HSALNT0017720,HSALNT0017721,HSALNT0017722,HSALNT0017723,HSALNT0017724,HSALNT0017725,HSALNT0017726,HSALNT0017728,HSALNT0017732,HSALNT0017737,HSALNT0017738,HSALNT0017739,HSALNT0017740,HSALNT0017744,HSALNT0017748,HSALNT0017749,HSALNT0017751,HSALNT0017753,HSALNT0017757,HSALNT0017760,HSALNT0017768,HSALNT0017773,HSALNT0017776,HSALNT0017777,HSALNT0296610,HSALNT0296611,HSALNT0296612,HSALNT0296613,HSALNT0296614,HSALNT0296615,HSALNT0296616,HSALNT0296617,HSALNT0296619,HSALNT0296620,HSALNT0296621,HSALNT0296622,HSALNT0296623,HSALNT0296624,HSALNT0296625,HSALNT0296626,HSALNT0296627,HSALNT0296628,HSALNT0296629,HSALNT0296630,HSALNT0296631,HSALNT0296632,HSALNT0296633,HSALNT0296634,HSALNT0296635,HSALNT0296636,HSALNT0296637,HSALNT0296638,HSALNT0296639,HSALNT0296640,HSALNT0296641,HSALNT0296642,HSALNT0296643,HSALNT0296644,HSALNT0296645,HSALNT0296646",,NA,,Disease,coronary artery disease,Blood,NA,NA,NA,NA,RNA,Down-regulated,NA,NA,NA,NA,PCG,MTOR,NA,Inhibit,QRT-PCR;Wetern blotting assay;Roc;RNAi;Q-RCR,NA,Cancer progression,NA,NA,NA,NA,"Compared with normal healthy people,expression level of lncRNA novlnc6 was significantly reduced in patients with cad and diabetes mellitus,but not in patients with other types of cardiovascular diseases,such as hypertension,abnormal aortic aneurysm,viral myocarditis.In addition,the expression level of gas5 was significantly lower in patients with cad compared to patients with diabetes mellitus.Roc curve analysis showed that gas5 may serve as a promising biomarker for cad.Gas5 knockdown and overexpression showed no significant effect on the level of mtor) in hcaecs.However,gas5 knockdown significantly increased the level of phospho-mtor (p-mtor),and gas5 overexpression significantly decreased the level of p-mtor.Treatment with mtor inhibitor and activator showed no significant effect on expression of gas5 in hcaecs.Gas5 plays a role as upstream regulator of the mtor pathway to participate in the development of cad.Gas5 was specifically downregulated in patients with cad,and it may serve as a promising biomarker for cad.Plasma long non-coding rna (lncRNA) gas5 is a new biomarker for coronary artery disease.Gas5 knockdown significantly increased the level of phospho-mtor (p-mtor),and gas5 overexpression significantly decreased the level of p-mtor.Gas5 plays a role as upstream regulator of the mtor pathway to participate in the development of cad.",29267258
H19,D11S813E;ASM;ASM1;NCRNA00008;LINC00008;MIR675HG,11p15.5,HSALNG0082178,"HSALNT0171121,HSALNT0171122,HSALNT0171123,HSALNT0171124,HSALNT0171125,HSALNT0289462,HSALNT0361012,HSALNT0361013,HSALNT0361014,HSALNT0361015,HSALNT0361016,HSALNT0361017,HSALNT0361018,HSALNT0361019,HSALNT0361020,HSALNT0361021,HSALNT0361022,HSALNT0361023,HSALNT0361024,HSALNT0361025,HSALNT0361026,HSALNT0361027,HSALNT0361028,HSALNT0361029,HSALNT0361030,HSALNT0361031",,NA,,Disease,coronary artery disease,Blood,NA,NA,NA,NA,RNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Genotyping,NA,NA,NA,NA,NA,NA,Re-expression of h19 has been observed in patients with atherosclerosis.Common polymorphisms of h19 are associated with the risk and severity of cad in a chinese population.The a variant of h19 snp rs2067051 was associated with a decreased risk of cad.The t variant of h19 snp rs217727 was associated with an increased risk of cad.,25772106
HOTTIP,HOXA-AS6;RP1-170O19.3;HOXA13-AS1;NCRNA00213,7p15.2,HSALNG0056871,"HSALNT0120381,HSALNT0120382,HSALNT0120383,HSALNT0120385,HSALNT0120386,HSALNT0120387,HSALNT0120388,HSALNT0120390,HSALNT0120392,HSALNT0120397,HSALNT0339947,HSALNT0339948,HSALNT0339949,HSALNT0339950,HSALNT0339951,HSALNT0339952,HSALNT0339953,HSALNT0339954,HSALNT0339955,HSALNT0339956,HSALNT0339957",,NA,,Disease,coronary artery disease,Coronary artery disease(cad) tissue;Normal arterial tissue,NA,NA,NA,NA,RNA,Up-regulated,NA,NA,NA,NA,NA,NA,NA,NA,QRT-PCR;Cell migration assay;Wetern blotting assay;Cell proliferation assays,NA,NA,NA,NA,NA,NA,"In this study,wedemonstrated that long noncoding rna (lncRNA) hoxa transcript at the distal tip (hottip) expression level was higher in coronary artery disease (cad) tissues than in normal arterial tissues.The expression level of hottip was upregulated in the proliferating endothelial cells induced by tnf-or pdgf-bb.Ectopic expression of hottip promoted endothelial cell proliferation and also increased the expression of proliferating makers cyclin d1 and pcnamoreover,elevated expression of hottip promoted endothelial cell migration.Downregulation expression of hottip suppressed endothelial cell proliferation and migration.Furthermore,wedetermined that overexpression of hottip induced βcatenin expression and enhanced the downstream protein c-myc expression in the endothelial cell.Ectopic expression of hottip increased endothelial cell proliferation and migration via activation of the wnt/β-catenin pathway.",29058802
IGF2-AS,PEG8;IGF2-AS1;IGF2AS,11p15.5,HSALNG0082197,"HSALNT0289463,HSALNT0361032,HSALNT0361033,HSALNT0361034,HSALNT0361035,HSALNT0361036",,NA,,Disease,coronary artery disease,Blood,NA,NA,NA,NA,RNA,Up-regulated,NA,NA,NA,NA,NA,NA,NA,NA,Microarray;Q-RCR,NA,NA,NA,NA,NA,NA,"31 lncRNAs were differentially expressed between the two groups,among whom,25 were upregulated in the cad group and six were downregulated.Four of the selected five lncRNAs were significantly upregulated in the cad group,and upperhand had the largest area under the curve (auc).The diagnostic value of upperhand was tested further,and it remained having a high diagnostic value.	.",29168540
